In the first quarter of 2024, the official website of the FDA updated the GRAS status of 27 products. Among these, approval was granted for 2 substances, 2 substances ceased to be evaluated at the notifier’s request, and 23 substances are still pending after submission.
This article provides a summary of the US FDA GRAS acceptance and approval status in the first quarter of 2024, for the information and reference of businesses.
1. Approved FDA GRAS substances in the first quarter of 2024 (FDA has no questions)
No. | GRN No. | Substance | Date of approval | Applicant |
1 | Protein-sucrose | 2024.1.19 | Incredo Ltd. (Israel) | |
2 | Brazzein | 2024.3.11 | Oobli, Inc. (US) |
2. Substances ceased to be evaluated at the notifier’s request in the first quarter of 2024
No. | GRN No. | Substance | Date | Applicant |
1 | Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3 | 2024.2.8 | Runke Bioengineering (Fujian) Co., Ltd. (China) | |
2 | Fungal oil (≥ 38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01 | 2024.2.8 | Runke Bioengineering (Fujian) Co., Ltd. (China) |
3. Pending substances in the first quarter of 2024
No. | GRN No. | Substance | Applicant |
1 | Hydroxytyrosol | Hangzhou Viablife Biotec (China) | |
2 | Transglutaminase enzyme preparation produced by Bacillus licheniformis carrying a gene encoding transglutaminase from Streptomyces mobaraensis | Novozymes North America (US) | |
3 | Enzyme-modified steviol glycosides | Tate & Lyle (US) | |
4 | L-α-glycerophosphorylcholine | Shenyang Gold Jyouki Technology Co., Ltd (China) | |
5 | Bacillus subtilis NRRL 68053 | Microbial Discovery Group (US) | |
6 | Miracle fruit (Synsepalum dulcificum) powder | Miracle Fruit Farm LLC (US) | |
7 | β-lactoglobulin produced by Aspergillus oryzae strain Ao_st0002 | Imagindairy Ltd. (Israel) | |
8 | Nuclease enzyme preparation produced by Bacillus amyloliquefaciens expressing the gene encoding a nuclease from Serratia marcescens | c-LEcta GmbH (Germany) | |
9 | Copper(II) ion | Copperprotek SPA (Chile) | |
10 | D-psicose | Daesang Corporation (South Korea) | |
11 | High-selenium Saccharomyces cerevisiae yeast | Cypress Systems, Inc. (US) | |
12 | Triacylglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene for triacylglycerol lipase from Thermomyces lanuginosis | AB Enzymes Inc. (US) | |
13 | Fava ben protein | Cooperative Koninklijke Cosun U.A. (Netherlands) | |
14 | Phoenix oyster mushroom (Pleurotus pulmonarius) mycelia biomass | Mushlabs GmbH (Germany) | |
15 | Pongamia bean oil | Terviva, Inc. (US) | |
16 | Triacylglycerol lipase enzyme preparation produced by Komagataella phaffii expressing the gene encoding lipase from Fusarium oxysporum | Lallemand Inc. (Canada) | |
17 | 1-methylcyclopropene | Fresh Inset S.A. (Poland) | |
18 | 2'-fucosyllactose | Synaura Biotechnology (Shanghai) Co., Ltd. (China) | |
19 | Lactiplantibacillus plantarum DSM 34613 | Scott Laboratories, Inc. (US) | |
20 | Bacillus coagulans strain BCP92 spore preparation | Pellucid Lifesciences Pvt., Limited (India) | |
21 | Lemna leaf protein | Plantible Food (US) | |
22 | Triacylglycerol lipase enzyme preparation produced by Candida cylindracea | Meito Sangyo Co., Ltd (Japan) | |
23 | A preparation containing two bacteriophages (phage) specific to Salmonella enterica | Cytophage Technologies inc. (Canada) |
Source: The inventory of GRAS notices, for reference only.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.